Lumea
PrivateLast Round
Strategic
Apr 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lumea is a healthcare technology company that provides a specialty-specific digital pathology platform and tissue-handling technology designed to streamline cancer diagnostic workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumea Comparables
Compare Lumea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proscia | 81% | |
| Tempus | 79% | |
| Techcyte, Inc. | 79% | |
Lumea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 9, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Completed a strategic funding round.
Lumea Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumea's valuation, stock price, and market status.